“CRISPR” is the word in the headline that signals that the piece is going to be about gene editing. Doc Gumshoe did not want to put that word – actually, it’s not really a word, but an acronym – in the title of this piece because gene editing is a whole lot more than […]
Articles
When we’re trying to fight against an adversary that is as strong and full of tricks as cancer, what we need to do is look for points of vulnerability – Achilles heels. We all remember, of course, that the mother of Achilles dipped him in the River Styx when he was a tiny boy, […]
Putting the name of this imperious disease in the title of my homily places a weighty responsibility on me. Who am I to attempt to put forth relevant information and sensible opinions on this topic, the mere mention of which makes most normal folk distinctly uneasy? But I probably pay more attention to […]
Every now and then a reader sends in a question about one of the stock ideas teased by dividend.com, which is a service that looks for, you guessed it, dividend paying stocks. Their standard “tease” is that they send around some hints about the latest stock they’ve added to one of their “best” lists, but […]
[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]
I wrote about Louis Navellier’s “solar monopoly” pitch a little while ago, but there was a also a cancer-fighting stock teased in that ad… and a few folks have been asking about that second stock, so I’ll see what we can do to get the Thinkolator on the case. Here’s a bit of the ad: […]
[ed. note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who writes for us a couple times a month about health issues and trends. He does not typically write about specific investment opportunities, but has agreed to our trading restrictions… as with all of our authors, […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]
[Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trade restrictions, chooses his own topics, and his words and opinions are his own. You can see all his past articles and recent comments here.] The State of Things is a classy 1982 Wim Wenders film in which a film […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, choses his own topics, and his words and opinions are his own. You can see his past columns and most recent comments on his Stock Gumshoe page.] We first presented Gilead ($GILD) as a long idea […]
Everybody’s got to deviate from the norm. —Rush John Galsworthy wrote that the beginning and endings of human undertakings are untidy. It was never more so than in the early days of HCV, a mere 20 years ago, when a plague first called “non-A non-B hepatitis” began vexing people, progressively scarring their livers and behaving […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his past articles and most recent comments here.] “Doctor doctor, what do you say, let’s put the id back in yid,” Portnoy groused to […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. His bio, past articles, and most recent comments can be seen here. Enjoy!] OUT of the night that covers me, Black as the Pit from pole to pole, I thank […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He choses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Enjoy!] In his smoky baritone, singer Stuart Staples of British midlands musical act Tindersticks is bemoaning how he suspects the woman he […]
Gumshoe BioDimSum II: Corralling the “A” Biotechs Plus a New Long Selection[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up […]
[ed note: Michael Jorrin, who I like to call “Doc Gumshoe”, is a longtime medical writer (not a doctor) who shares his thoughts with us from time to time, generally on non-financial topics in health and medicine (as today, though, he mentions a couple publicly traded companies). His words and opinions are his own.] The […]
[ed note: Michael Jorrin is a longtime medical writer (not a doctor) who covers health and medical topics and trends for our readers, generally without an investment thesis. His words are his own, enjoy!] In the Doc Gumshoe blog about cancer that appeared in June of 2013 (you can check it out here), I commented […]
[ed note: Dr. KSS is a paid contributor to Stock Gumshoe who writes about biotech stocks for (and discusses them with) the Irregulars. He chooses his own topics, and his words and opinions are his alone. Enjoy!] Greetings fellow Irregulars! You’ve all been waiting for it….our first-ever annual ceremony in which we look back on […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. His previous columns can be found here. Enjoy!] Every New Year, a friend and I flew to Boston. She’d gone to medical school […]
We’ve got a good teaser to solve today, but first — a quick plea: This will be our final week of “Gumshoe Gives Back” this year — we will be donating at least half of all the membership contributions received through the rest of this week (until the end of the day on Friday, 12/12) […]
In his tearjerker “Sisters of Mercy,” Leonard Cohen sings, I’ve been where you’re hanging and think I can see how you’re pinned. Although I am less inclined to bash the FDA than many, it has recently let modern medical practice place many patients in an undesirable situation. What if there was a very powerful drug, […]
Immunotherapy for cancer has been in the news quite a bit in recent years, with several drugs making an impact on the worst cancers and giving some real hope for future advancement — not a small thing for a basic medical strategy that’s been tested and tweaked for 125 years now by folks following in […]
[ed note: Michael Jorrin, a medical writer who we have dubbed “Doc Gumshoe” (he’s not a doctor), shares his thoughts with us once or twice a month — what follows is his latest missive, the words and opinions below are his alone.] I didn’t plan it this way, but the timing of this Doc Gumshoe […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]
[Ed. Note: Here is the latest contribution from Dr. KSS, who writes for the Irregulars about medicine and biomedical stocks. As always, he has agreed to our trading restrictions and his words and thoughts are his own.] The Belle of the Everglades How To Profit From The Cure First of Two Parts Of the many […]
[Ed. Note: Here is our second installment from Dr. KSS, formerly known as “karmaswimswami” in Gumshoe discussion threads. Dr. KSS has agreed to our trading and disclosure restrictions, and he’s not offering you personal investment or medical advice. As with all of our columnists, we don’t assign topics or opinions and do just a bit of light […]
[ed note: We feature the musings of our favorite health and medicine writer, Michael Jorrin, a couple times a month, and we’ve taken the liberty of calling him “Doc Gumshoe” (he’s not a doctor). You’ll find no stock picks in his pieces, but hopefully will get plenty of insight into the medical matters he explains […]
[ed note: Another piece from “Doc Gumshoe” today — Michael Jorrin is not a doctor, he’s a longtime medical writer who we love because he explains diseases, treatments, and health controversies in a way that makes sense. The words and opinions shared below are his alone. If you’re curious about whether rheumatoid arthritis matters to […]
I’ve got a handful of updates for you, including one on a stock that I bought yesterday and a few other notes about recent quarterly reports from stocks I follow, but first … a teaser to solve … When I wrote about Marc Lichtenfeld’s pitch for “Spread Trusts” yesterday, I promised to also try to […]
As promised, we’re following up with the rest of the picks that Stephen Leeb (sorry, Dr. Stephen Leeb) is pitching as his “MCR” Plan. If you missed our first entry as we began demystifying this particular ad, you can see it here — the short version is, he’s touting dividend paying stocks in the medical […]
Comments
Apparently David Garner has a new buy recommendation: Globus Medical (GMED)...
M. Fool when defining differences: NET offers more service, like domain hosting, website optimization, firewall, etc. ...
Travis do you know Motley fool 2019/20 blast off portfolio picks or these moonshot stock picks thanks...
What about MOTLEY FOOLS DOUBLE DOWN STOCK???...
THANK YOU TRAVIS ! EXACTLY WAT I WAS THINKING ABOUT WHITNEY TILSON ......brag ra, brag HIS SUCCESSES, NOT FOR OURS! KE...
The stock they pretty regularly tease they've bought "$523,111" worth of is Arista Networks, FYI (I've covered that seve...
@Elgordo wrote: "... doing covered stock exposes you to possible large losses." Actually, covered calls are one of the l...
I haven't seen any teases for this "Netflix Killer" that include any clues, but I'd be surprised if it's not yet another...
What is the Netflix Killer mentioned by Motley Fool?...
Travis mentioned that stocks that both Motley Fool brothers agreed on (only happened 23 times total) have been extremely...
This has been teased before https://www.stockgumshoe.com/reviews/motley-fool-rule-breakers/fools-the-tiny-black-box-that...
That's almost certainly a rejiggering of some older Motley Fool teases about Tencent. Haven't covered that specific ad,...
I've never been able to justify owning it (to my detriment), but haven't seen the Motley Fool promote it in teaser ads i...
Hi Travis, are you sure about IIVI being the recommendation? I ask because the video presentation says that the stocks t...
Don't think I've looked at that one in years, though if I remember it was the first "Internet of things" stock pitched b...
Your narrative speaks of a speculative gain which did not materialize because the name of the stock was not provided to ...
PLNT is also a Motley Fool recommendation....
My bad. Somehow I thought you owned MMYT. I bought a small position anticipating the potential. So far it has not worked...
Maddogne, if you are a Motley Fool member, does the Tradestops warning come at a decisively quicker time than an email f...
Good to see many favorable reviews here. Do they also have stock picks (like Motley fool Stock advisor) or just Call an...
I subscribe to Motley Fool Rule Breakers and previously their Stock Advisor. Nearly all of the core stocks I bought at ...
Thanks for reminding me that these special dividends rarely work out. Some years ago, Motley fool hyped FCX for a speci...
"1 (Still Small) CA-Based Company Is Exploding". I rec'd this in an email from "The Motley Fool" today, May 21, 2019. ...
Markel get 21% when rated by the Nasdaq Guru analysis using Motley Fool methology!...
Agreed Dortelli. It seems that some of these companies were started by guys who were probably unfit and/ or untrained fo...
What does Motley Fool recommend?...
@JimmyZ I use The Motley Fool, fool.ca,fool.com, and subscribe to three of their premiums right now. I'm just a beginn...
Is this topic of Project iris still relevant in April 2019? Just saw Motley Fool came out with an article about an Apple...
I'm sick of the same story he's used to tease everyone for over a year there is no company is my opinion .He just wants ...
Just try to find a phone #. Motley Fool is becoming a marketing scam but a bit smarter about flying under the legal rad...
I applaud Citron for coming out with their promise to donate $200k to charity if $SHOP trades for more than $200/per sha...
I have joined several times to the Motley fool stock advisers. I am exhausted looking for stocks, so I get frustrated ...
I have been a motley fool subscriber from almost day one and I have done very well - mostly due to Netflix - I am up 5,0...
Is this the same marijuana stock that Motley Fool is teases...
Solid work from Motley fool, SA is their best and most valuable newsletter. Bad part - they re-recommend same picks so...
Sorry if I'm stepping on your toes- but I'm so surprised someone would write what you wrote I've got to share my truth: ...
I’m very new to the world of newsletters and opinion pieces. And very new to investing. I’m interested in the cannab...
Don't know the current portfolios, but in the past they were hugely influenced by a few mega-winners (Marvel/Disney, Net...
Those AI pitches from Motley Fool Canada have mostly been about BlackBerry or OpenText -- covered here: https://www.stoc...
Picking stocks is like that old joke about the plumber who gives the client a $100. Bill. The customer becomes infuriate...
I was wondering if VIVO.T might fit. They purchased a company in B.C. that has revenue in the $15 mil neighborhood.The M...
It's a new industry, and there will likely be dramatic winners and losers over the next five or ten years -- I would ima...
Motley Fool just put out a bunch of weed stock recommendations. Their teaser would be a good one to gumshoe....
I just saw this tease for the first time today, but evidently, it has been around for months. It is interesting the no...
Motley Fool wants people to buy because they want to dump their stock. On February 5, about the same time as the "Tripl...
I go to Stock Gumshoe for one overriding reason: to "cut to the chase." This is the first time (checking out the Motley...
After months of paid subscriptions with the Fool the only “fool” was me. Of my entire portfolio the only positions i...
Nice article about ANET, thx Travis. Just a few notes since you mentioned The $8k price at Motley Fool, I think that is...
This just out from the Motley Fool folks on TELL: https://www.fool.com/investing/2019/01/12/forget-cheniere-energy-te...
Pretty impressed with these folks. I've subscribed to quite a few other newsletters from Motley Fool to a dozen others b...
I read in motley about the 50 billion pot stock...a CEO put billions into it. Is that hydropothecary? What does gunshoe...
This program launched recommending immediate buys of twelve stocks, many of which had already risen by multiples of 100%...
I think also #ROKU Motley fool also says a California startup.A little-known California company went public—and it’...
Welcome to the "I lost money using the Motley Fool Advisory Service" club!...
We know that almost all of these are snake oil. Hard to believe that many people go for these newsletters. The best know...
Speaking of "World's Greatest Stock Picker", thought I would mention that Motley Fool is pitching another portfolio (ano...
Does anyone besides me think Motley Fool has way too many programs? Stock Advisor; Rulebreakers; Options; Moneymakers; ...
Lots of bull hockey from Motley Fool newsletters. Wild predictions and they deluge you with come-ons like so many others...
Lots of bull hockey from Oxford letters. Wild predictions and they deluge you with come-ons like so many others: Mampill...
5 Élite U.S. Stocks Set to Explode Go to Portfolio Grader- You dont hâve to be member Enter symbol of small cap s...
I think it's NVDIA, Travis. Maybe you should give a look into that. You could also be right and I'm definitely not an ex...
There's an old article on the Motley Fool website that talks about how Citi has been part of the cause of every financia...
The Fool is pitching this stock for a long time. Tom Gardner even called it his No one suggestion period! They are up qu...
Long $IIPR: $IIPR is up $3.29 (7.84%) today, partially on good earnings news, but I think it's also due to favorable men...
It was this pitch that suckered me into Motley Fool a few years back. I bought Discover and Scripps right away and they...
EDIT and CELG are Motley Fool favorites also. Lost money on CELG....
I second all that you said. PM is so much more comprehensive and I always learn something every time he sends his podcas...
I will add that I am a long-term subscriber to the MF Pro and Options services, which have gotten a bit pricier on the l...
I did a little research on another IPO from October 2017. Did Motley Fool recommend ROKU? Their numbers are similar ...
Thanks for the insight, Thinkolator. I’ve been wondering what the “top ten” Motley Fool stocks are that the Fool h...
I have been investing 25 years used to be a licensed broker, and also have been so very well served by the Motley Fool I...
Thanks, feedback always appreciated — it doesn’t have to be negative :) I do have a lot of respect for the Gardne...
I'm just not sure how to feel about Motley Fool. They seem to have some good ideas, but I'm turned off by the way they ...
Stock Gumshoe just released an article "What’s “Tom Gardner’s favorite marijuana stock?” on your exact question ...
Motley Fool is a service that tips stocks to its high payers first, then trickles down to the medium payers and ordinary...
Motley Fool has been advocating The Trade Desk, Inc. (TTD) for some time. I tend to agree with Travis on the attractiv...
I am currently subscribed to motley fool stock advisor. I don't see any of these stocks(NXPI or BEAT) in the portfolio....
Wow,so many comments on pot...wanted to add Motley Fool comments I just read..he said do NOT buy CRON,TLRY or ACBFF righ...
What is the double down the motley fool is pushing...
I subscribed to motley fool stock advisor and took a flyer with them in rule breakers and a couple others. I was buildin...
On September 5th, Motley Fool compared Sierra Wireless with Nividia and determined Nividia to be the better buy....
Whatever works to get attention is used over and over until it stops working. Agora and the Motley Fool are particularl...
Hi Travis, I’m a new member. Thank you so much for your service. I subscribed to the Motley Fool many years ago, mid...
The guy has to be Mark Henri Leonard who is worth abound 1 billion not 20 billion. Constellation is worth about $20 Bil...
I found that Motley Fool is a scam and I no longer subscribe to them....
Sounds like it’s a repeat of one they’ve run for a while, maybe time to update that article — my older coverage is...
The offer email i saw from the Motley Fool had these statements in it.. "Major Announcement: Our best iPhone investi...
I’ve been trying out a few “experts” and recently checked my Motley Fool track record from email alerts I’ve rec...
Just clicked on this thread. I purchased some Markel way back in January of 2006 upon some recommendations in the Motle...
The "Japanese billionaire" can only refer to Son Masayoshi. His biggest investments are listed here: https://www.recode...
The Pot is certainly Cooking - it is without a doubt the hottest and most talked about sector. Motley Fool recently p...
In the article it mentions that "In this report, Motley Fool co-founder David Gardner dives deep into three companies po...
Ok what is the stock? I’ve joined Motley Fool about three or four times in the last 10 years and all I get is advert...
I don't have access to Motley Fool, but the hint pretty clearly matches Tencent (HK:0700 or TCEHY are two ways I see it ...
Wade3 - maybe we're not smarter than you? For myself I had no idea why CleanTeq had been/is hemorrhaging and was also w...
Thanks guys to all comments and best of luck as I’ve joined as a free member at this stage. I’ve just started to b...
I totally get it. I got one subscription from Motley Fool that I didn't need, & told them I'd love it, but then I'd ...
This Canadian AI stock is being recommended by Motley Fool....
What's this brand new Motley Fool teaser stock they're claiming is Amazon's Project Vesta (domestic robots) supplier? I...